Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimer: 0893-9675
ISSN En ligne: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2013007934
pages 449-461

Iron in Multiple Myeloma

Kristina VanderWall
Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine
Tracy R. Daniels-Wells
Division of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine
Manuel Penichet
Division of Surgical Oncology, Department of Surgery, UCLA David Geffen School of Medicine; The Jonsson Comprehensive Cancer Center, The Molecular Biology Institute, Department of Microbiology, Immunology, and Molecular Genetics, UCLA
Alan Llichtenstein
Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine; The Jonsson Comprehensive Cancer Center, UCLA; The Greater Los Angeles VA Medical Center, Los Angeles, California

RÉSUMÉ

Multiple myeloma is a non-curable B-cell malignancy in which iron metabolism plays an important role. Patients with this disorder almost universally suffer from clinically significant anemia, which is often symptomatic, and which is due to impaired iron utilization. Recent studies have indicated that the proximal cause of dysregulated iron metabolism and anemia in these patients is cytokine-induced upregulation of hepcidin expression. Malignant myeloma cells are dependent on an increased influx of iron, and therapeutic efforts are being made to target this requirement. The studies detailing the characteristics and biochemical abnormalities in iron metabolism causing anemia and the initial attempts to target iron therapeutically are described in this review.


Articles with similar content:

A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Warren D. W. Heston, Mike Gong, Michel Sadelain, Jason Tasch
Sirtuins in Hematological Aging and Malignancy
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 6
Mendel Roth, Zhiqiang Wang, WenYong Chen
Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 5
Frank M. Torti, Suzy V. Torti
Mechanisms of Yin Yang 1 in Oncogenesis: The Importance of Indirect Effects
Critical Reviews™ in Oncogenesis, Vol.16, 2011, issue 3-4
Michael L. Atchison, Kristina Zaprazna, Arindam Basu, Madhusudhan Papasani
Regulation of Allergy with RNA Interference
Critical Reviews™ in Immunology, Vol.29, 2009, issue 6
Xiufen Zheng, Yuwei Zhang, Thomas E. Ichim, Xusheng Zhang, Weiping Min, Motohiko Suzuki